165 related articles for article (PubMed ID: 27749408)
21. Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von hippel-lindau-associated pancreatic lesions.
Sadowski SM; Weisbrod AB; Ellis R; Patel D; Alimchandani M; Quezado M; Millo C; Venzon DJ; Nilubol N; Linehan WM; Kebebew E
J Am Coll Surg; 2014 May; 218(5):997-1003. PubMed ID: 24661849
[TBL] [Abstract][Full Text] [Related]
22. CT diagnosis of unsuspected von Hippel-Lindau disease.
Kuhlman JK; Fishman EK; Marshall FF; Siegelman SS
Urology; 1987 Nov; 30(5):505-8. PubMed ID: 3672691
[TBL] [Abstract][Full Text] [Related]
23. Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.
Hou G; Cheng X; Chi Y; Wang X; Zheng R
Clin Nucl Med; 2024 Mar; 49(3):289-291. PubMed ID: 38306383
[TBL] [Abstract][Full Text] [Related]
24. Germline VHL gene variant in patients with von Hippel-Lindau disease does not predict renal tumor growth.
Farhadi F; Nikpanah M; Li X; Symons R; Pourmorteza A; Merino MJ; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2018 Oct; 43(10):2743-2749. PubMed ID: 29525880
[TBL] [Abstract][Full Text] [Related]
25. A Von Hippel-Lindau Disease-Associated Microcystic Adenoma of the Ethmoid Sinus Mimicking Metastatic Clear Cell Renal Cell Carcinoma.
Tsukamoto S; Koyasu S; Sugimoto A; Matsunaga M; Nakamoto Y
Clin Nucl Med; 2023 Feb; 48(2):194-196. PubMed ID: 36179325
[TBL] [Abstract][Full Text] [Related]
26. Different manifestations detected with 68Ga-DOTATOC PET/CT in patients with Von Hippel-Lindau disease: A case report.
Meneret P; Girard A; Pagenault M; Riffaud L; Palard-Novello X
Nuklearmedizin; 2020 Aug; 59(4):332-334. PubMed ID: 32193881
[No Abstract] [Full Text] [Related]
27. Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target.
Sizdahkhani S; Feldman MJ; Piazza MG; Ksendzovsky A; Edwards NA; Ray-Chaudhury A; Maric D; Merrill MJ; Pacak K; Zhuang Z; Chittiboina P
Sci Rep; 2017 Jan; 7():40822. PubMed ID: 28094316
[TBL] [Abstract][Full Text] [Related]
28. FDG PET/CT detects clinically occult pancreatic cancer in a case of Von Hippel-Lindau syndrome.
Kulkarni M; Purandare N; Zade A; Agrawal A; Shah S; Rangarajan V
Clin Nucl Med; 2013 Jul; 38(7):e302-3. PubMed ID: 23486326
[TBL] [Abstract][Full Text] [Related]
29. Imaging findings of pancreatic cystic lesions in von Hippel-Lindau disease.
Kobayashi N; Sato T; Kato S; Watanabe S; Hosono K; Shimamura T; Iida H; Endo H; Koide T; Takahashi H; Yoneda M; Shibata W; Abe Y; Inamori M; Kirikoshi H; Saito S; Maeda S; Nakajima A; Kubota K
Intern Med; 2012; 51(11):1301-7. PubMed ID: 22687833
[TBL] [Abstract][Full Text] [Related]
30. The kidney imaging surveillance scoring system (KISSS): using qualitative MRI features to predict growth rate of renal tumors in patients with von-Hippel Lindau (VHL) syndrome.
Gopal N; Anari PY; Chaurasia A; Antony M; Wakim P; Linehan WM; Ball M; Turkbey E; Malayeri A
Abdom Radiol (NY); 2024 Feb; 49(2):542-550. PubMed ID: 38010527
[TBL] [Abstract][Full Text] [Related]
31. Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.
Weisbrod AB; Kitano M; Gesuwan K; Millo C; Herscovitch P; Nilubol N; Linehan WM; Kebebew E
J Clin Endocrinol Metab; 2012 Apr; 97(4):E613-7. PubMed ID: 22259055
[TBL] [Abstract][Full Text] [Related]
32. The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients.
Cleary JO; Yeung J; McMeekin H; Wilhelm T; Wagner T
Nucl Med Commun; 2016 Nov; 37(11):1197-205. PubMed ID: 27399848
[TBL] [Abstract][Full Text] [Related]
33. Potential value of EUS in pancreatic surveillance of VHL patients.
van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Koopmans KP; Kema IP; Zonnenberg BA; Timmers HJ; de Herder WW; Sluiter WJ; de Vries EG; Links TP
Eur J Endocrinol; 2016 May; 174(5):611-20. PubMed ID: 26884551
[TBL] [Abstract][Full Text] [Related]
34. CT screening of the abdomen in von Hippel-Lindau disease.
Levine E; Collins DL; Horton WA; Schimke RN
AJR Am J Roentgenol; 1982 Sep; 139(3):505-10. PubMed ID: 6981314
[TBL] [Abstract][Full Text] [Related]
35. Preliminary PET/CT Imaging with Somatostatin Analogs [
Satpati D; Shinto A; Kamaleshwaran KK; Sarma HD; Dash A
Mol Imaging Biol; 2017 Dec; 19(6):878-884. PubMed ID: 28349291
[TBL] [Abstract][Full Text] [Related]
36. Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group.
Oudard S; Elaidi R; Brizard M; Le Rest C; Caillet V; Deveaux S; Benoit G; Corréas JM; Benoudiba F; David P; Gaudric A; Hammel P; Joly D; Timsit MO; Méjean A; Richard S
Oncotarget; 2016 Dec; 7(51):85306-85317. PubMed ID: 27852035
[TBL] [Abstract][Full Text] [Related]
37. Von Hippel-Lindau Disease With Multi-Organ Involvement: A Case Report and 8-Year Clinical Course With Follow-Up.
Yaghobi Joybari A; Azadeh P
Am J Case Rep; 2017 Nov; 18():1220-1224. PubMed ID: 29146893
[TBL] [Abstract][Full Text] [Related]
38. PET/CT With 68Ga-DOTA-TATE for Diagnosis of Neuroendocrine: Differentiation in Patients With Castrate-Resistant Prostate Cancer.
Gofrit ON; Frank S; Meirovitz A; Nechushtan H; Orevi M
Clin Nucl Med; 2017 Jan; 42(1):1-6. PubMed ID: 27775942
[TBL] [Abstract][Full Text] [Related]
39. [Radiological diagnosis of visceral manifestations in Hippel-Lindau syndrome (author's transl)].
Wittich G; Czembirek H; Fridrich L; Imhof H
Radiologe; 1980 Nov; 20(11):534-9. PubMed ID: 7208885
[TBL] [Abstract][Full Text] [Related]
40. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.
Breer S; Brunkhorst T; Beil FT; Peldschus K; Heiland M; Klutmann S; Barvencik F; Zustin J; Gratz KF; Amling M
Bone; 2014 Jul; 64():222-7. PubMed ID: 24769333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
